JLS Pharma SRL
2.6 FTEJLS Pharma reported total assets of 232,526 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026), with 2.6 full-time equivalents.
The score of JLS Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -61 % Total assets -1 % Headcount (avg FTE) -7 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
JLS Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 06 Oct 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
JLS Pharma's financial analysis
- Solvency12.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of JLS Pharma
JLS Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0771.655.091
- VAT number
- BE0771655091
- Peppol
- Registered · 0208:0771655091 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Jul 2021
- Registered office
- 5081 La Bruyère
- Size
- Micro · 2.6 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
JLS Pharma (SRL) has been based in La Bruyère since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 71,664 € and equity of 29,426 €; its revenue is not published. With 2.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 12.7%, below the median of its sector (41.5%).
Companies similar to JLS Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Apotheek Debackere Leen Retail sale of pharmaceutical products Aalter · balance sheet 354,864 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Pharmaela Retail sale of pharmaceutical products Quaregnon · balance sheet 286,114 €
- De Hermitage Retail sale of pharmaceutical products Bruges · balance sheet 202,742 €
- Vivapharma Retail sale of pharmaceutical products Auderghem · balance sheet 236,296 €
- Lynapharma Retail sale of pharmaceutical products Saint-Gilles · balance sheet 177,178 €
- Sivahe Retail sale of pharmaceutical products Hasselt · balance sheet 172,297 €
Frequently asked questions about JLS Pharma
What is the revenue of JLS Pharma?
JLS Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of JLS Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0771655091 for JLS Pharma, if the company is VAT-registered. Its company number (CBE) is 0771.655.091.
Where is the registered office of JLS Pharma?
According to the CBE register, the registered office of JLS Pharma is in 5081 La Bruyère.
What is the equity of JLS Pharma?
At the close of the 2025 financial year, the equity of JLS Pharma amounts to 29,426 €, a solvency of 12.7% of total assets.
How many people work at JLS Pharma?
2.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages JLS Pharma?
The register lists 2 active mandates at JLS Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of JLS Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →